Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer-Reference-Cited by-同舟云学术

Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer

Published:2024-03 Issue:3 Volume:9 Page:102903
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Marín-Aguilera M.,Jares P.,Sanfeliu E.,Villacampa G.,Hernández-lllán E.,Martínez-Puchol A.I.^ORCID,Shankar S.,González-Farré B.,Waks A.G.,Brasó-Maristany F.,Pardo F.,Manning D.K.,Abery J.A.,Curaba J.,Moon L.,Gordon O.,Galván P.,Wachirakantapong P.^ORCID,Castillo O.,Nee C.M.,Blasco P.^ORCID,Senevirathne T.H.^ORCID,Sirenko V.,Martínez-Sáez O.,Aguirre A.,Krop I.E.,Li Z.,Spellman P.,Metzger Filho O.,Polyak K.^ORCID,Michaels P.^ORCID,Puig-Butillé J.A.^ORCID,Vivancos A.,Matito J.,Buckingham W.,Perou C.M.^ORCID,Villagrasa-González P.,Prat A.,Parker J.S.,Paré L.^ORCID

Funder

Generalitat de Catalunya Agencia de Gestio d'Ajuts Universitaris i de Recerca

Instituto de Salud Carlos III

Fundación Fero

Breast Cancer Research Foundation

Horizon 2020

Fundación Científica de la Asociación Española Contra el Cáncer

Publisher

Elsevier BV

Reference14 articles.

1. Targeting HER2-positive breast cancer: advances and future directions;Swain;Nat Rev Drug Discov,2023

2. Dissecting the biological heterogeneity of HER2-positive breast cancer;Schettini;Breast,2021

3. Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor–positive breast cancer;Cronin;Clin Chem,2007

4. Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens;Nielsen;BMC Cancer,2014

5. Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer;Prat;EBioMedicine,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance;Nature Reviews Clinical Oncology;2024-09-13

2. Genomic tests for risk stratification in patients with early human epidermal growth factor receptor 2-positive breast cancer;Current Opinion in Oncology;2024-07-25

3. HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from the PHERGain Phase II Trial;Clinical Cancer Research;2024-07-12